Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription 08.09.2025 12 AIDS 4 AIDS Res Hum Retroviruses 1 Antimicrob Agents Chemother 1 BMC Cancer 4 Clin Infect Dis 5 HIV Med 1 Int J Cancer 4 J Acquir Immune Defic Syndr 2 J Infect Dis 3 J Med Virol 1 J Virol 2 Lancet Infect Dis 3 N Engl J Med 1 Pediatrics 1 PLoS Med 7 PLoS One 1 PLoS Pathog 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. PATEL N, Dulion B, Lazcano I, Shi Q, et al
   Antiretroviral-specific associations between bone hormonal changes and treatment induced weight gain.
   AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004330.
   PubMed         Abstract available
   
   
2. SATRE DD, Sarovar V, Levine T, Alexeeff S, et al
   The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multi-site cohort study.
   AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004329.
   PubMed         Abstract available
   
   
3. DURSTENFELD MS, Nance RM, Jones R, Abelman R, et al
   Predicting risk of cardiovascular events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort.
   AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004331.
   PubMed         Abstract available
   
   
4. GIULIANI M, Zaccarelli M, Stingone C, Gianserra L, et al
   The paradox of rising syphilis among MSM living with HIV amid declining HIV infections: a 33-year analysis.
   AIDS. 2025;39:1841-1844.
   PubMed         Abstract available
   
   
5. GROENEWALD P, Glass T, Kallis N, Holmgren C, et al
   Under-reporting of HIV and AIDS as an underlying cause of death in South Africa.
   AIDS. 2025;39:1839-1841.
   PubMed         Abstract available
   
   
6. SCHAEFER R, Lievense B, Day S, Donaldson L, et al
   Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research.
   AIDS. 2025;39:1835-1838.
   PubMed        
   
   
7. LESKO CR, Marshall BDL
   The cost of defunding HIV surveillance systems in the United States.
   AIDS. 2025;39:1833-1834.
   PubMed        
   
   
8. VANCE DE, Layton S
   Posttraumatic stress disorder and Veterans with HIV: commentary on neurocognition, social cognition, and resilience.
   AIDS. 2025;39:1828-1830.
   PubMed        
   
   
9. MASENGA SK, Capeau J
   Myosteatosis in HIV: the adipose tissue connection.
   AIDS. 2025;39:1825-1827.
   PubMed        
   
   
10. ARENAS-PINTO A, Abrescia N, Abdel-Hameed EA
    Metabolic dysfunction-associated steatotic liver disease and liver fibrosis in people with HIV.
    AIDS. 2025;39:1822-1824.
    PubMed        
    
    
11. DAWOOD H
    The role of ECG in risk prediction for sudden cardiac and unexpected death in people with HIV.
    AIDS. 2025;39:1820-1821.
    PubMed        
    
    
12. VANCE DE, Lee J
    Social cognition abilities in people with HIV: the role of stigma and other factors.
    AIDS. 2025;39:1688-1698.
    PubMed         Abstract available
    
    

    
    AIDS Res Hum Retroviruses

13. ZHAO F, Liu Z, Jia J, Zhang Z, et al
    Characterization of Two Novel HIV-1B/CRF01_AE/CRF07_BC Recombinant Forms Among Men Who Have Sex with Men in Hebei Province, China.
    AIDS Res Hum Retroviruses. 2025 Sep 2. doi: 10.1177/08892229251374704.
    PubMed         Abstract available
    
    
14. NGUYEN E, Korolkova A, Ahmed A, Meanley S, et al
    Participant Perspectives in an HIV Treatment Interruption Study in San Francisco, United States.
    AIDS Res Hum Retroviruses. 2025 Sep 2. doi: 10.1177/08892229251375470.
    PubMed         Abstract available
    
    
15. PENG J, Song Y, Chen Z, Xu L, et al
    Enhancing HIV Genotyping and Drug-Resistance Detection in Low Viral Load Samples Through Exosome Enrichment Technology.
    AIDS Res Hum Retroviruses. 2025 Sep 2. doi: 10.1177/08892229251374705.
    PubMed         Abstract available
    
    
16. MADLALA HP, Myer L, Geffen H, Jao J, et al
    Maternal Anthropometry, Body Composition, and Fat Distribution by HIV Status and Antiretroviral Therapy Class in South African Women.
    AIDS Res Hum Retroviruses. 2025 Sep 3. doi: 10.1177/08892229251374692.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

17. WANG C, Huang H, Valera L, Parcella K, et al
    Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499.
    Antimicrob Agents Chemother. 2025 Sep 3:e0030925. doi: 10.1128/aac.00309.
    PubMed         Abstract available
    
    

    
    BMC Cancer

18. MALTSEVA M, Klasen C, Wuerdemann N, Hannich M, et al
    Detection and natural history of HPV infection of oral cavity and tonsils - a systematic literature review.
    BMC Cancer. 2025;25:1405.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

19. BECK IA, Boyce CL, Bishop MD, Oldroyd AR, et al
    HIV resistance to dolutegravir varies with co-administered agents.
    Clin Infect Dis. 2025 Sep 2:ciaf481. doi: 10.1093.
    PubMed         Abstract available
    
    
20. BARDA B, Bongiovanni M
    Long-acting cabotegravir/rilpivirine in viraemic people with HIV: bumpy raod to perfection.
    Clin Infect Dis. 2025 Sep 1:ciaf482. doi: 10.1093.
    PubMed        
    
    
21. DAVIES SMITH E, Douglas PS, McCallum S, Troendle J, et al
    Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings.
    Clin Infect Dis. 2025 Sep 1:ciaf477. doi: 10.1093.
    PubMed         Abstract available
    
    
22. SEIBERT AM, Matheu M, Buckel WR, Bledsoe J, et al
    Increasing HIV Testing During Gonorrhea and Chlamydia Evaluations in Urgent Care and Emergency Departments: A Large Health System Initiative.
    Clin Infect Dis. 2025 Sep 1:ciaf434. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

23. PIERONE G JR, Brunet L, Fusco JS, Sension MG, et al
    Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real-world evidence from the OPERA cohort.
    HIV Med. 2025 Aug 30. doi: 10.1111/hiv.70105.
    PubMed         Abstract available
    
    
24. ORLOVA-MOROZOVA E, Kireev D, Kirichenko A, Bobkov V, et al
    Real-world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV-1 sub-subtype A6 harbouring the L74I mutation.
    HIV Med. 2025;26:1463-1467.
    PubMed         Abstract available
    
    
25. STOYANOVA A, Foster F, Savin P, Amanzholov N, et al
    Examination of factors associated with mental health of people living with HIV in Kazakhstan: A cross-sectional study based on the two-continua model.
    HIV Med. 2025 Sep 5. doi: 10.1111/hiv.70100.
    PubMed         Abstract available
    
    
26. DZANDO G, Ward PR, Mwanri L, Agbadi P, et al
    Multidimensional frailty, sex differences, and quality of life among older Ugandans affected by HIV.
    HIV Med. 2025 Sep 5. doi: 10.1111/hiv.70111.
    PubMed         Abstract available
    
    
27. HASEBE S, Kusaka T, Tanaka M, Iwane S, et al
    Dual drivers of polypharmacy in people with HIV: Quantifying the independent associations of aging and long-term antiretroviral therapy.
    HIV Med. 2025 Sep 5. doi: 10.1111/hiv.70106.
    PubMed         Abstract available
    
    

    
    Int J Cancer

28. SAEEDI E, Nemati S, Lotfi F, Domingues A, et al
    IRANCANSURV: A comprehensive analysis of childhood cancer survival in Iran.
    Int J Cancer. 2025 Sep 1. doi: 10.1002/ijc.70100.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

29. KELLY NK, Ranapurwala SI, Pence BW, Hightow-Weidman LB, et al
    The effect of state-level policy climate on HIV pre-exposure prophylaxis use and the role of internalized stigma.
    J Acquir Immune Defic Syndr. 2025 Sep 4. doi: 10.1097/QAI.0000000000003760.
    PubMed         Abstract available
    
    
30. MORGAN E, McDade TW, Manning W, Kamp Dush CM, et al
    Assessing Inflammatory Biomarkers at the Intersection of Marijuana and PrEP Use: Preliminary findings from the NCHAT-BIO study.
    J Acquir Immune Defic Syndr. 2025 Sep 4. doi: 10.1097/QAI.0000000000003759.
    PubMed         Abstract available
    
    
31. KNETTEL BA, Madundo K, Amiri I, Msoka EF, et al
    Results of a Pilot Randomized Controlled Trial of IDEAS for Hope, a Brief Telehealth Intervention for Suicide Prevention and HIV Care Engagement in Tanzania.
    J Acquir Immune Defic Syndr. 2025 Sep 4. doi: 10.1097/QAI.0000000000003758.
    PubMed         Abstract available
    
    
32. SPENCE AB, Visconti A, Goparaju L, Wingood G, et al
    Anticipated protection overcomes vaccine hesitancy and mistrust among women enrolled in the DC MACS/WIHS Combined Cohort Study.
    J Acquir Immune Defic Syndr. 2025 Sep 3. doi: 10.1097/QAI.0000000000003757.
    PubMed         Abstract available
    
    

    
    J Infect Dis

33. LEONE P, Ferro A, Rolle CP, Lupo S, et al
    VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Anti-drug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results.
    J Infect Dis. 2025 Sep 2:jiaf450. doi: 10.1093.
    PubMed         Abstract available
    
    
34. CHURIWAL M, Kintu TM, Byamukama O, Bassett IV, et al
    HIV and syphilis coinfection in pregnancy and adverse birth outcomes in Uganda.
    J Infect Dis. 2025 Aug 30:jiaf453. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

35. PRATES G, Li X, Folgosi V, Souza G, et al
    Persistent Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection in the Placenta of Pregnant Women.
    J Med Virol. 2025;97:e70585.
    PubMed         Abstract available
    
    
36. BOUCHER J, Bazie WW, Goyer B, Alary M, et al
    HIV-1 RNA in Large and Small Plasma Extracellular Vesicles: A Novel Parameter for Monitoring Immune Activation and Virological Failure.
    J Med Virol. 2025;97:e70574.
    PubMed         Abstract available
    
    
37. GALARZA P, Aguerre L, Procopio D, Krogh DH, et al
    Frequency of the CCR5Delta32 Variant in Haematopoietic Progenitor Cell Donors From Argentina: Implications for Transplantation in HIV-1 Infected Patients.
    J Med Virol. 2025;97:e70591.
    PubMed         Abstract available
    
    

    
    J Virol

38. JOSEPH R, Marais G, Iranzadeh I, Alisoltani A, et al
    Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2.
    J Virol. 2025 Sep 5:e0078025. doi: 10.1128/jvi.00780.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

39. 
    Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet Infect Dis. 2025 Aug 28:S1473-3099(25)00361.
    PubMed         Abstract available
    
    
40. TIRLANGI PK, Khan AR, Soneja M, Gupta N, et al
    Preventing vertical HIV transmission in India: the final push.
    Lancet Infect Dis. 2025 Sep 2:S1473-3099(25)00535.
    PubMed        
    
    

    
    N Engl J Med

41. SIEDNER MJ, Magula N, Mazibuko L, Sithole N, et al
    Home-Based Care for Hypertension in Rural South Africa.
    N Engl J Med. 2025 Sep 1. doi: 10.1056/NEJMoa2509958.
    PubMed         Abstract available
    
    
42. HOOK EW 3RD, Dionne JA, Workowski K, McNeil CJ, et al
    One Dose versus Three Doses of Benzathine Penicillin G in Early Syphilis.
    N Engl J Med. 2025;393:869-878.
    PubMed         Abstract available
    
    
43. BARBEE LA, Bachmann LH
    Antiquated Tools to Fight an Ancient Foe.
    N Engl J Med. 2025;393:921-923.
    PubMed        
    
    

    
    Pediatrics

44. DOW D, Rahim F, Nasuwa F, O'Donnell K, et al
    Mental Health Care Gaps for Adolescents With HIV: Lessons From Tanzania and the United States.
    Pediatrics. 2025;156.
    PubMed         Abstract available
    
    

    
    PLoS Med

45. SIKOMBE K, Le Tourneau N, Rice B, Pry JM, et al
    Identifying care gaps along the HIV treatment failure cascade: A multistate analysis of viral load monitoring, re-suppression, and regimen switches in Zambia.
    PLoS Med. 2025;22:e1004720.
    PubMed         Abstract available
    
    

    
    PLoS One

46. NHAMO D, Chibanda D, Cowan FM, Duma SE, et al
    A qualitative analysis of female sex workers' lived experiences with adherence to Pre-exposure Prophylaxis (PrEP) in Zimbabwe.
    PLoS One. 2025;20:e0313366.
    PubMed         Abstract available
    
    
47. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.
    PLoS One. 2025;20:e0327243.
    PubMed         Abstract available
    
    
48. BULAMBA RM, Kyasanku E, Nalugoda F, Daama A, et al
    Assessing Knowledge, Uptake and Factors associated with cervical cancer screening among women in selected communities of Wakiso district in Uganda: A population-based study.
    PLoS One. 2025;20:e0317641.
    PubMed         Abstract available
    
    
49. WEBER SF, Wolf R, Manten K, Thangakunam B, et al
    Lung and abdominal ultrasound accuracy for tuberculosis: An Indian prospective cohort study.
    PLoS One. 2025;20:e0329670.
    PubMed         Abstract available
    
    
50. STOCKTON MA, Waddell K, Mphonda SM, Bhushan NL, et al
    Suicide assessment and feasible evidence-based treatments for adolescents living with HIV in Malawi: Protocol for a pilot randomized controlled trial.
    PLoS One. 2025;20:e0330847.
    PubMed         Abstract available
    
    
51. ISKAKOVA B, King EJ, Yucel RM, DeHovitz J, et al
    "I think they are infected because of their ignorance and lack of responsibility": A mixed-methods study on HIV-related stigma in the healthcare system in Kazakhstan.
    PLoS One. 2025;20:e0331201.
    PubMed         Abstract available
    
    
52. SHANGANI S, Reeves JM, Heron K, Sales JM, et al
    Willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among black cisgender women in the Southern United States.
    PLoS One. 2025;20:e0330698.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

53. LEWIS CA, Margolis DM, Browne EP
    HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells.
    PLoS Pathog. 2025;21:e1013073.
    PubMed         Abstract available
    
    

    
    Science

54. COHEN J
    Dividends from death.
    Science. 2025;389:968-971.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.